Ads for Pfizer's Celebrex downplays risks

Although Celebrex has been through the ringer in recent years as the painkiller category where it is sold has been linked to heart problems, the advertising for the drug looks to be not telling the whole story.

A consumer group asked that ads for Pfizer's Celebrex stop being run across the nation since this new marketing appears to downplay the safety differences between Celebrex and other painkillers.

After two years of no advertising on the Celebrex front, critics are sure to keep Pfizer on its toes about telling a balanced story on that product from here on out. Kudos to them.